Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.6363524368.3651
Domestic EquitiesTorrent Pharmaceuticals Ltd.6.6125131305.2005
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.950067234.6795
Domestic EquitiesAurobindo Pharma Ltd.4.8065313013.7802
Domestic EquitiesDivi's Laboratories Ltd.4.737961583.7262
Domestic EquitiesFortis Healthcare Ltd.4.6590430323.6642
Domestic EquitiesNeuland Laboratories Ltd.4.355425853.4254
Domestic EquitiesPiramal Pharma Ltd.4.29462183613.3776
Domestic EquitiesAlkem Laboratories Ltd.3.615350082.8433
Domestic EquitiesAbbott India Ltd.3.39289682.6683
Domestic EquitiesCipla Ltd.3.2941195672.5907
Domestic EquitiesNavin Fluorine International Ltd.3.191941162.5103
Domestic EquitiesGland Pharma Ltd.3.1348133512.4654
Domestic EquitiesIPCA Laboratories Ltd.3.1051166042.4421
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.0744119942.4179
Domestic EquitiesArtemis Medicare Services Ltd.2.9487935292.3191
Domestic EquitiesConcord Biotech Ltd.2.9100194742.2886
Domestic EquitiesOnesource Specialty Pharma Ltd.2.8343186612.2291
Domestic EquitiesMetropolis Healthcare Ltd.2.7190114172.1384
Domestic EquitiesMankind Pharma Ltd.2.316485771.8218
Domestic EquitiesDr Agarwal's Health Care Ltd.2.1777395761.7127
Domestic EquitiesMax Healthcare Institute Ltd.2.0408167751.6050
Domestic EquitiesGlobal Health Ltd.2.0034149521.5756
Domestic EquitiesAnthem Biosciences Ltd.1.7497229611.3761
Domestic EquitiesSyngene International Ltd.1.7013282601.3380
Domestic EquitiesVinati Organics Ltd.1.696787411.3344
Domestic EquitiesAcutaas Chemicals Ltd.1.531062961.2041
Total 95.4895 75.0996
Cash & Cash Equivalents and Net AssetsTreps4.3424 3.4152
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.1681 0.1322
Total 4.5105 3.5474
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.